Abbott India Ltd

₹ 27,795 4.10%

11 May - close price

abbott.co.in BSE: 500488 NSE: ABBOTINDIA

About

Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.^[1] It was established in 1944.^[2]

Key Points

Abbott Group
The company is a part of Abbott Laboratories, USA which has a presence in 160 countries with leading medical devices, diagnostics, nutrition products, and branded generic medicines. ^[1]

Website BSE NSE

Market Cap ₹ 59,150 Cr.
Current Price ₹ 27,795
High / Low ₹ 37,000 / 25,150
Stock P/E 38.8
Book Value ₹ 1,888
Dividend Yield 1.71 %
ROCE 46.2 %
ROE 35.7 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.
Company has delivered good profit growth of 19.0% CAGR over last 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 34.2%
Company has been maintaining a healthy dividend payout of 72.2%

Cons

Stock is trading at 14.7 times its book value
The company has delivered a poor sales growth of 9.38% over past five years.
Working capital days have increased from 24.9 days to 97.2 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE 500 BSE Healthcare BSE 200 BSE Dollex 200 Nifty 500 Nifty Pharma Nifty MNC BSE 150 MidCap Index BSE 250 LargeMidCap Index BSE 400 MidSmallCap Index BSE Quality Index Nifty LargeMidcap 250 Nifty 500 Multicap 50:25:25 Nifty Healthcare Index Nifty Midcap 150 Nifty MidSmallcap 400 Nifty Midcap150 Quality 50 Nifty Total Market Nifty MidSmall Healthcare Nifty Midcap150 Momentum 50 BSE 200 Equal Weight Nifty MidSmall India Consumption Nifty500 Equal Weight Nifty500 LargeMidSmall Equal-Cap Weighted BSE 1000 BSE 500 Quality 50 Nifty500 Healthcare

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
	1,322	1,343	1,479	1,494	1,437	1,439	1,558	1,633	1,614	1,605	1,738	1,757	1,724
	1,010	1,063	1,124	1,113	1,049	1,109	1,167	1,194	1,178	1,176	1,293	1,255	1,261
Operating Profit	312	280	355	381	388	330	391	439	436	429	446	502	463
OPM %	24%	21%	24%	25%	27%	23%	25%	27%	27%	27%	26%	29%	27%
	44	50	56	56	56	81	67	60	72	76	73	70	70
Interest	4	4	3	3	3	3	3	2	2	4	6	8	5
Depreciation	18	17	17	18	18	18	18	18	18	18	19	19	19
Profit before tax	335	308	390	415	422	390	437	479	488	483	493	546	509
Tax %	26%	25%	26%	25%	26%	26%	25%	25%	26%	24%	26%	24%	26%
	247	231	290	313	311	287	328	359	361	367	366	415	376
EPS in Rs	116.16	108.91	136.59	147.27	146.35	135.09	154.36	168.76	169.78	172.73	172.18	195.43	176.93
Raw PDF

Upcoming result date: today

Profit & Loss

Figures in Rs. Crores

	Mar 2014 15m	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	2,276	2,289	2,614	2,903	3,298	3,679	4,093	4,310	4,919	5,349	5,849	6,409	6,824
	2,009	1,977	2,250	2,505	2,774	3,074	3,336	3,388	3,832	4,143	4,396	4,714	4,984
Operating Profit	267	312	365	398	525	605	757	922	1,088	1,206	1,453	1,695	1,840
OPM %	12%	14%	14%	14%	16%	16%	18%	21%	22%	23%	25%	26%	27%
	49	48	50	57	117	113	114	81	77	154	248	275	289
Interest	0	0	3	2	4	2	9	18	19	16	12	11	23
Depreciation	22	15	14	16	16	17	60	58	66	70	71	72	75
Profit before tax	295	344	398	436	621	699	803	926	1,080	1,274	1,618	1,887	2,031
Tax %	33%	34%	36%	37%	35%	36%	26%	25%	26%	25%	26%	25%
	198	229	255	277	401	450	593	691	799	949	1,201	1,414	1,524
EPS in Rs	93.39	107.75	120.12	130.19	188.82	211.93	279.04	325.04	375.87	446.80	565.30	665.64	717.27
Dividend Payout %	25%	29%	29%	31%	29%	31%	90%	85%	73%	73%	73%	71%

Compounded Sales Growth
10 Years:	11%
5 Years:	9%
3 Years:	9%
TTM:	9%

Compounded Profit Growth
10 Years:	20%
5 Years:	19%
3 Years:	21%
TTM:	14%

Stock Price CAGR
10 Years:	20%
5 Years:	11%
3 Years:	9%
1 Year:	-8%

Return on Equity
10 Years:	30%
5 Years:	32%
3 Years:	34%
Last Year:	36%

Balance Sheet

Figures in Rs. Crores

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	21	21	21	21	21	21	21	21	21	21	21	21	21
Reserves	767	916	1,174	1,366	1,672	1,987	2,410	2,581	2,799	3,167	3,678	4,212	3,990
	0	0	0	0	0	0	175	153	152	113	83	197	182
	351	436	421	679	723	932	940	1,086	1,253	1,254	1,411	1,487	1,501
Total Liabilities	1,139	1,374	1,616	2,066	2,416	2,941	3,547	3,840	4,224	4,556	5,193	5,917	5,694
	98	96	108	110	81	105	270	251	271	237	225	336	314
CWIP	1	4	3	6	2	1	2	1	1	4	10	18	23
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0
	1,040	1,274	1,505	1,950	2,333	2,835	3,275	3,589	3,952	4,315	4,958	5,563	5,357
Total Assets	1,139	1,374	1,616	2,066	2,416	2,941	3,547	3,840	4,224	4,556	5,193	5,917	5,694

Cash Flows

Figures in Rs. Crores

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	155	215	249	307	153	499	626	727	948	893	1,213	1,012
	-144	-187	-77	-155	-215	-257	-401	-72	-396	-148	-416	182
	-42	-58	-80	-90	-102	-143	-217	-582	-637	-639	-745	-925
Net Cash Flow	-31	-30	91	62	-165	99	8	73	-86	107	52	269
Free Cash Flow	151	199	226	287	180	504	611	704	904	860	1,165	960
CFO/OP	99%	106%	109%	117%	68%	125%	113%	104%	114%	102%	111%	86%

Ratios

Figures in Rs. Crores

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	18	21	20	22	29	27	28	21	21	22	20	22
Inventory Days	101	107	91	107	112	106	83	110	94	80	70	92
Days Payable	38	54	56	101	92	116	104	116	122	109	114	110
Cash Conversion Cycle	80	74	54	28	49	17	8	14	-6	-8	-24	3
Working Capital Days	36	30	32	21	63	22	10	4	-7	-8	-14	97
ROCE %	39%	40%	38%	34%	41%	37%	35%	35%	38%	41%	46%	46%

Insights

In beta

Mar 2014

Mar 2015

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Employee Strength (Total Headcount)
Number

x,xxx	x,xxx	x,xxx	x,xxx	x,xxx	x,xxx	x,xxx	x,xxx	x,xxx	x,xxx	x,xxx	x,xxx
	x,xxx	xx	x,xxx	x,xxx	x,xxx			x,xxx	x,xxx	x,xxx	x,xxx
	xx.xx	xx.xx	x.xx	xx.xx		xx.xx		xx.xx	x.xx	xx.xx	xx.xx
	xx.xx	xx.xx	xx.xx	xx.xx		xx.xx	x.xx	x.xx		x.xx	x.xx
			xx	xx	xx	xx	xx	x	xx	xx	x
							xx		xx
						x,xxx	x,xxx
									xx

Please log in to see hidden values.

Dealers and Distributors Network
Number

Goa Plant Liquid Volume Growth
Percentage

Goa Plant Tablet Volume Growth
Percentage

New Product Launches (Annual)
Count

Dydrogesterone Market Share (Duphaston)
Percentage

Field Force Strength
Number

Share of Products under NLEM
Percentage

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%
	0.19%	0.19%	0.18%	0.18%	0.18%	0.17%	0.17%	0.16%	0.16%	0.16%	0.19%	0.27%
	8.77%	8.83%	8.73%	8.91%	8.81%	9.00%	9.01%	8.91%	9.18%	9.11%	9.00%	8.93%
	16.05%	16.01%	16.09%	15.92%	16.01%	15.86%	15.85%	15.94%	15.67%	15.74%	15.83%	15.81%
No. of Shareholders	69,582	68,885	72,252	69,382	71,588	69,449	67,892	69,934	67,584	71,199	75,801	75,866

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%
	2.74%	2.82%	1.90%	1.64%	1.01%	0.22%	0.19%	0.18%	0.16%	0.27%
	6.14%	6.62%	7.14%	6.08%	5.53%	7.52%	8.61%	8.91%	8.91%	8.93%
	16.13%	15.58%	15.98%	17.30%	18.47%	17.27%	16.20%	15.92%	15.94%	15.81%
No. of Shareholders	23,004	22,583	26,624	49,254	84,478	90,567	72,086	69,382	69,934	75,866

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Abbott India Ltd

Abbott India Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Insights

Shareholding Pattern

Documents

Announcements

Annual reports

Concalls